Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1977 Dec;6(6):627–632. doi: 10.1128/jcm.6.6.627-632.1977

Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

J D Kettering, N J Schmidt, D Gallo, E H Lennette
PMCID: PMC274835  PMID: 201664

Abstract

An anti-complement immunofluorescence (ACIF) test that detects human cytomegalovirus (CMV) antigen in the nuclei of infected cells was used for assay of CMV antibodies in human sera. Various factors influencing the sensitivity and specificity of the ACIF test system were investigated, and results were applied to the development of a procedure which could be completed in a relatively short length of time and gave reproducible results. Results obtained in the ACIF test were compared with those obtained in complement fixation, indirect hemagglutination, and neutralization tests, and the ACIF test was shown to be suitable for detection of significant antibody titer rises and stationary levels of CMV antibody. Heterotypic antibody responses were not seen with sera from other human herpesvirus infections. The nonspecific cytoplasmic staining that occurs in indirect immunofluorescence tests for CMV did not occur in the ACIF system, and sera that were anti-complementary in complement fixation tests could be examined satisfactorily by ACIF. Thus, the test is a valuable supplemental or back-up procedure for the serodiagnosis of CMV infection.

Full text

PDF
628

Images in this article

628Image
on p.628

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein M. T., Stewart J. A. Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol. 1971 Jan;21(1):84–89. doi: 10.1128/am.21.1.84-89.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cremer N. E., Schmidt N. J., Jensen F., Hoffman M., Oshiro L. S., Lennette E. H. Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus. J Clin Microbiol. 1975 Mar;1(3):262–267. doi: 10.1128/jcm.1.3.262-267.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Forghani B., Schmidt N. J., Lennette E. H. Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems. Infect Immun. 1976 Nov;14(5):1184–1190. doi: 10.1128/iai.14.5.1184-1190.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fuccillo D. A., Moder F., Traub R. G., Hensen S., Sever J. L. Micro indirect hemagglutination test for Cytomegalovirus. Appl Microbiol. 1971 Jan;21(1):104–107. doi: 10.1128/am.21.1.104-107.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Furukawa T., Hornberger E., Sakuma S., Plotkin S. A. Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J Clin Microbiol. 1975 Oct;2(4):332–336. doi: 10.1128/jcm.2.4.332-336.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henle W., Guerra A., Henle G. False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen. Int J Cancer. 1974 Jun 15;13(6):751–754. doi: 10.1002/ijc.2910130603. [DOI] [PubMed] [Google Scholar]
  7. Krech U., Jung M., Sonnabend W. A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections. Z Immunitatsforsch Exp Klin Immunol. 1971 Jun;141(5):411–429. [PubMed] [Google Scholar]
  8. Moss D. J., Pope J. H. EB Virus-associated nuclear antigen production and cell proliferation in adult peripheral blood leukocytes inoculated with the QIMR-WIL strain of EB virus. Int J Cancer. 1975 Mar 15;15(3):503–511. doi: 10.1002/ijc.2910150316. [DOI] [PubMed] [Google Scholar]
  9. Reedman B. M., Hilgers J., Hilgers F., Klein G. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens. Int J Cancer. 1975 Apr 15;15(4):566–571. doi: 10.1002/ijc.2910150406. [DOI] [PubMed] [Google Scholar]
  10. Schmidt N. J., Dennis J., Lennette E. H. Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells. J Clin Microbiol. 1976 Jul;4(1):61–66. doi: 10.1128/jcm.4.1.61-66.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schmidt N. J., Lennette E. H., Woodie J. D., Ho H. H. Immunofluorescent staining in the laboratory diagnosis of varicella-zoster virus infections. J Lab Clin Med. 1965 Sep;66(3):403–412. [PubMed] [Google Scholar]
  12. Schmitz H., Kampa D., Heidenreich W. Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne. Int J Cancer. 1975 Dec 15;16(6):1030–1034. doi: 10.1002/ijc.2910160617. [DOI] [PubMed] [Google Scholar]
  13. Spencer E. S., Andersen H. K. The development of immunofluorescent antibodies as compared with complement-fixing and virus-neutralizing antibodies in human cytomegalovirus infection. Scand J Infect Dis. 1972;4(2):109–112. doi: 10.3109/inf.1972.4.issue-2.08. [DOI] [PubMed] [Google Scholar]
  14. Swack N. S., Michalski F. J., Baumgarten A., Hsiung G. D. Indirect fluorescent-antibody test for human cytomegalovirus infection in the absence of interfering immunoglobulin G receptors. Infect Immun. 1977 May;16(2):522–526. doi: 10.1128/iai.16.2.522-526.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tarro G., Giordano G. G., Tripodi A., Cerra R., Di Gioia M., Battista A., Smeraglia R. Herpes simplex virus nuclear nonvirion antigens detected by anticomplement immunofluorescence. Tumori. 1976 Nov-Dec;62(6):609–614. doi: 10.1177/030089167606200604. [DOI] [PubMed] [Google Scholar]
  16. Westmoreland D., St Jeor S., Rapp F. The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin. J Immunol. 1976 Jun;116(6):1566–1570. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES